Learning Objectives:
- Identify several classes of glucose-lowering medications with proven benefits in improving cardiovascular outcomes.
- Be able to summarize key messages from current practice guidelines for patients with type 2 diabetes and cardiovascular disease.
- Understand the value of a coordinated team-based approach afforded by the Cardiometabolic Center of Excellence model.
Session date:
01/27/2023 - 12:00pm to 1:00pm CST
Location:
Zoom
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Mikhail Kosiborod, MD, FACC, FAHA